13-57633507-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001040429.3(PCDH17):c.961G>T(p.Val321Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000415 in 1,613,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
PCDH17
NM_001040429.3 missense
NM_001040429.3 missense
Scores
3
11
5
Clinical Significance
Conservation
PhyloP100: 6.93
Genes affected
PCDH17 (HGNC:14267): (protocadherin 17) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein contains six extracellular cadherin domains, a transmembrane domain, and a cytoplasmic tail differing from those of the classical cadherins. The encoded protein may play a role in the establishment and function of specific cell-cell connections in the brain. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.41651085).
BS2
High AC in GnomAd4 at 25 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH17 | NM_001040429.3 | c.961G>T | p.Val321Leu | missense_variant | 1/4 | ENST00000377918.8 | NP_001035519.1 | |
PCDH17 | XM_005266357.3 | c.961G>T | p.Val321Leu | missense_variant | 2/5 | XP_005266414.1 | ||
PCDH17 | XM_047430276.1 | c.961G>T | p.Val321Leu | missense_variant | 2/5 | XP_047286232.1 | ||
PCDH17 | XM_017020547.2 | c.961G>T | p.Val321Leu | missense_variant | 1/4 | XP_016876036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH17 | ENST00000377918.8 | c.961G>T | p.Val321Leu | missense_variant | 1/4 | 1 | NM_001040429.3 | ENSP00000367151 | P1 | |
ENST00000610846.1 | n.69C>A | non_coding_transcript_exon_variant | 1/2 | 4 | ||||||
PCDH17 | ENST00000484979.5 | c.961G>T | p.Val321Leu | missense_variant, NMD_transcript_variant | 1/4 | 1 | ENSP00000432899 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152192Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
25
AN:
152192
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 251204Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135878
GnomAD3 exomes
AF:
AC:
12
AN:
251204
Hom.:
AF XY:
AC XY:
5
AN XY:
135878
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461608Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727120
GnomAD4 exome
AF:
AC:
42
AN:
1461608
Hom.:
Cov.:
32
AF XY:
AC XY:
28
AN XY:
727120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74352
GnomAD4 genome
AF:
AC:
25
AN:
152192
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.961G>T (p.V321L) alteration is located in exon 1 (coding exon 1) of the PCDH17 gene. This alteration results from a G to T substitution at nucleotide position 961, causing the valine (V) at amino acid position 321 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of catalytic residue at R324 (P = 0.032);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at